sorafenib,Lenvatinib,Atezolizumab,Bevacizumab
bayer,Roche,Eisai
[]
newer therapies demonstrate real-world benefit vs sorafenib in first-line hcc #gi23 #hcc 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.